Autobio Diagnostics Co., Ltd. (SHA:603658)
39.30
-0.03 (-0.08%)
May 13, 2025, 3:00 PM CST
Autobio Diagnostics Revenue
Autobio Diagnostics had revenue of 995.93M CNY in the quarter ending March 31, 2025, a decrease of -8.56%. This brings the company's revenue in the last twelve months to 4.38B, down -2.63% year-over-year. In the year 2024, Autobio Diagnostics had annual revenue of 4.47B with 0.62% growth.
Revenue (ttm)
4.38B
Revenue Growth
-2.63%
P/S Ratio
5.13
Revenue / Employee
758.35K
Employees
5,773
Market Cap
22.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.47B | 27.55M | 0.62% |
Dec 31, 2023 | 4.44B | 2.03M | 0.05% |
Dec 31, 2022 | 4.44B | 675.71M | 17.94% |
Dec 31, 2021 | 3.77B | 787.79M | 26.45% |
Dec 31, 2020 | 2.98B | 298.70M | 11.15% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |